Pharma Journalist -

Isotopia Molecular Imaging is pleased to announce that it has begun a collaboration with Y-mAbs Therapeutics, Inc., a late-stage clinical biopharmaceutical company, for the supply of…
Read More...

NanOlogy LLC, a clinical-stage oncology company advancing intratumoral therapy for solid tumors, has enrolled the first patient in a Phase 2 clinical trial of NanoPac (sterile…
Read More...

Axsome Therapeutics, Inc. and Veeva Systems announced a strategic partnership to augment the build of Axsome’s Digital-Centric Commercialization (DCC™) platform. Veeva is the leader in…
Read More...

XNK Therapeutics AB ("XNK") announced it has received Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (FDA) for its leading investigational drug candidate in…
Read More...

Bristol Myers Squibb announced positive results from POETYK PSO-1, the first pivotal Phase 3 trial evaluating deucravacitinib (BMS-986165), a novel, oral, selective tyrosine kinase 2…
Read More...

Ionis Pharmaceuticals, Inc. and its wholly owned subsidiary Akcea Therapeutics, Inc., announced that Pfizer Inc. has initiated a Phase 2b study of vupanorsen (AKCEA-ANGPTL3-LRx) in…
Read More...

GW Pharmaceuticals plc announced that the Company has initiated the first U.S. Phase 3 clinical trial studying nabiximols for multiple sclerosis (MS)-associated spasticity. Nabiximols,…
Read More...

ACG, a leading supplier of integrated pharmaceutical manufacturing solutions announced acquisition of a significant stake in Mumbai-based start-up IQGEN-X. IQGEN-X is a Contract…
Read More...

PerkinElmer, Inc. and Horizon Discovery Group plc are pleased to announce that they have reached an agreement on the terms of a recommended all cash offer whereby PerkinElmer will…
Read More...

Roche announced that the European Commission has approved Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) for the treatment of adult patients with advanced or…
Read More...